1. Complement inhibitor CSMD1 acts as a tumor suppressor in breast cancer by interacting with EGF receptor. (September 2017) Authors: Gialeli, Chrysostomi; Guleed, Safia; Bartoschek, Michael; Mörgelin, Matthias; Pietras, Kristian; Blom, Anna M. Journal: Molecular immunology Issue: Volume 89(2017:Sep.) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses. (2nd December 2018) Authors: Quandt, Jasmin; Schlude, Christoph; Bartoschek, Michael; Will, Rainer; Cid-Arregui, Angel; Schölch, Sebastian; Reissfelder, Christoph; Weitz, Jürgen; Schneider, Martin; Wiemann, Stefan; Momburg, Frank; Beckhove, Philipp Journal: Oncoimmunology Issue: Volume 7:Number 12(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Issue 1 (December 2018) Authors: Bartoschek, Michael; Oskolkov, Nikolay; Bocci, Matteo; Lövrot, John; Larsson, Christer; Sommarin, Mikael; Madsen, Chris; Lindgren, David; Pekar, Gyula; Karlsson, Göran; Ringnér, Markus; Bergh, Jonas; Björklund, Åsa; Pietras, Kristian Journal: Nature communications Issue: Volume 9:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗